PhaseRx, Inc.
PZRXQ · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|
| Revenue | $0 | $375 | $1,200 |
| % Growth | -100% | -68.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $375 | $1,200 |
| % Margin | – | 100% | 100% |
| R&D Expenses | $6,662 | $4,883 | $4,860 |
| G&A Expenses | $4,153 | $1,299 | $1,931 |
| SG&A Expenses | $11,668 | $1,299 | $1,931 |
| Sales & Mktg Exp. | $7,515 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $18,330 | $6,182 | $6,791 |
| Operating Income | -$18,330 | -$5,807 | -$5,591 |
| % Margin | – | -1,548.5% | -465.9% |
| Other Income/Exp. Net | -$1,807 | -$1,570 | -$1,258 |
| Pre-Tax Income | -$20,137 | -$7,377 | -$6,849 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$20,137 | -$7,377 | -$6,849 |
| % Margin | – | -1,967.2% | -570.8% |
| EPS | -2.68 | -0.94 | -1.16 |
| % Growth | -185.1% | 19% | – |
| EPS Diluted | -2.68 | -0.94 | -1.16 |
| Weighted Avg Shares Out | 7,524 | 7,882 | 5,895 |
| Weighted Avg Shares Out Dil | 7,524 | 7,882 | 5,895 |
| Supplemental Information | – | – | – |
| Interest Income | $61 | $0 | $0 |
| Interest Expense | $2,058 | $1,649 | $1,367 |
| Depreciation & Amortization | $136 | $331 | $512 |
| EBITDA | -$17,943 | -$5,397 | -$4,970 |
| % Margin | – | -1,439.2% | -414.2% |